Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Severe SARS-CoV2 Pneumonia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT04358952
What this trial is testing

Myocardial Involvement of Severe Acute Respiratory Syndrome-Cov-2 (Covid19) Infected Patients

Who this might be right for
Cardiomyopathies
University Hospital, Toulouse 122
Large-scale testing (Phase 3)Study completedNCT04321278
What this trial is testing

Safety and Efficacy of Hydroxychloroquine Associated With Azithromycin in SARS-CoV2 Virus (Coalition Covid-19 Brasil II)

Who this might be right for
Coronavirus InfectionsPneumonia, Viral
Hospital Israelita Albert Einstein 440
Not applicableWithdrawnNCT05256511
What this trial is testing

COVID-19 and VA-LRTI: Second Versus First Wave of the Pandemic

Who this might be right for
Severe COVID-19
University Hospital, Lille
Testing effectiveness (Phase 2)UnknownNCT05688839
What this trial is testing

Jaktinib Hydrochloride Tablets in the Treatment of Severe Novel Coronavirus Pneumonia

Who this might be right for
Novel COVID-19-Infected Pneumonia
Suzhou Zelgen Biopharmaceuticals Co.,Ltd 60
Not applicableStudy completedNCT04603677
What this trial is testing

Northern Colorado COVID-19 Biobank

Who this might be right for
Covid19
Colorado State University 148
Testing effectiveness (Phase 2)Study completedNCT04426695
What this trial is testing

Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for Hospitalized Adult Patients With COVID-19

Who this might be right for
COVID-19
Regeneron Pharmaceuticals 2,252
Not applicableStudy completedNCT04410107
What this trial is testing

Lung Function, Exercise Capacity and Health-Related Quality of Life After Severe COVID-19

Who this might be right for
COVID-19SARS-CoV-2 Infection
Federal University of Rio Grande do Sul 144
Not applicableWithdrawnNCT04573634
What this trial is testing

A Registry Study of COVID-19 Serologic and Virologic Testing to Accelerate Recovery and Transition

Who this might be right for
Covid19SARS-CoV Infection
Jill M Kolesar
Not applicableUnknownNCT04416100
What this trial is testing

Development of Interstitial Lung Disease (ILD) in Patients With Severe SARS-CoV-2 Infection (COVID-19)

Who this might be right for
Covid-19Pulmonary Fibrosis
Medical University Innsbruck 130
Large-scale testing (Phase 3)Study completedNCT05119855
What this trial is testing

Safety and Immunogenicity of 9-valent Human Papillomavirus (9vHPV) Vaccine Coadministered With Messenger Ribonucleic Acid (mRNA)-1273 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) (COVID-19) Vaccine (V503-076)

Who this might be right for
Papillomavirus InfectionsCoronavirus Disease (COVID-19)
Merck Sharp & Dohme LLC 165
Very early researchStudy completedNCT04931004
What this trial is testing

Oral Rinse to Reduced Expelled Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) During COVID-19 Infection

Who this might be right for
Covid19
Rutgers, The State University of New Jersey 34
Early research (Phase 1)UnknownNCT05218070
What this trial is testing

Safety and Immunogenicity Study of EgyVax Vaccine Candidate for Prophylaxis of COVID-19 Infection

Who this might be right for
COVID-19
Eva Pharma 45
Not applicableStudy completedNCT05268601
What this trial is testing

COVID-19 and Disease Progression to the Severe Form: a Study on the Use of Monoclonal Antibodies Against SARS-CoV-2

Who this might be right for
COVID-19
University of Milano Bicocca 251
Not applicableStudy completedNCT05115045
What this trial is testing

Plasma SARS-CoV-2 RNA Levels in Critically Ill COVID-19 Patients

Who this might be right for
COVID-19 PneumoniaARDS Due to Disease Caused by Severe Acute Respiratory Syndrome Coronavirus 2
Hopital of Melun 122
Post-approval studies (Phase 4)Ended earlyNCT04351191
What this trial is testing

PRophylaxis of Exposed COVID-19 Individuals With Mild Symptoms Using choloroquinE Compounds

Who this might be right for
Sars-CoV2Symptomatic ConditionCovid-19
Government of Punjab, Specialized Healthcare and Medical Education Department 137
Large-scale testing (Phase 3)Study completedNCT04518410
What this trial is testing

ACTIV-2: A Study for Outpatients With COVID-19

Who this might be right for
CoronavirusCovid19
National Institute of Allergy and Infectious Diseases (NIAID) 4,044
Testing effectiveness (Phase 2)UnknownNCT06002841
What this trial is testing

Extracellular Vesicles From Mesenchymal Cells in the Treatment of Acute Respiratory Failure

Who this might be right for
Severe Acute Respiratory Syndrome (SARS)Acute Respiratory Distress Syndrome (ARDS)Pneumonia
D'Or Institute for Research and Education 15
Large-scale testing (Phase 3)Study completedNCT04883203
What this trial is testing

The Effect of Vitamin D Supplementation on COVID-19 Recovery

Who this might be right for
Covid19
University of Monastir 130
Large-scale testing (Phase 3)Study completedNCT04466241
What this trial is testing

Combination Therapies to Reduce Carriage of SARS-Cov-2 and Improve Outcome of COVID-19 in Ivory Coast: a Phase Randomized IIb Trial

Who this might be right for
COVID-19COVID-19 Drug TreatmentSevere Acute Respiratory Syndrome Coronavirus 2
ANRS, Emerging Infectious Diseases 294
Not applicableUnknownNCT04738331
What this trial is testing

Analysing the French COVID-19 Epidemic Using a National SARS-CoV-2 RT-PCR Database

Who this might be right for
Covid-19SARS-CoV Infection
University Hospital, Montpellier 10,000,000
Next Page